Anthony Culverwell
Directeur/Membre du Conseil chez TC BIOPHARM (HOLDINGS) PLC
Fortune : - $ au 30/06/2024
Profil
Mr. Anthony J.
Culverwell is an Independent Director at TC Biopharm (Holdings) Plc, an Independent Director at Quoin Pharmaceuticals Ltd., a Founder at Sudbrook Associates LLP and a Chairman at Hox Therapeutics Ltd.
He is on the Board of Directors at TC Biopharm (Holdings) Plc, Quoin Pharmaceuticals Ltd.
and Safeguard Biosystems Holdings Ltd.
Mr. Culverwell was previously employed as a Senior Independent Non-Executive Director by Amryt Pharma Holdings Ltd., an Independent Member-Supervisory Board by Innocoll AG, a Member-Supervisory Board by Innocoll Holdings Plc, a Non-Executive Director by ATLANTIC HEALTHCARE LTD, a Non-Executive Director by Bioco Ltd., a Principal by Merrill Lynch & Co., Inc. /Old/, a Head-European Pharmaceutical Equity Research by Jefferies International Ltd., a Non-Executive Director by Expedeon Ltd., a Head-European Healthcare by Hoare Govett Ltd., an Analyst by Merrill Lynch, Pierce, Fenner & Smith Ltd., and a Non-Executive Director by ToHealth Ltd.
He also served on the board at Innocoll, Inc. He received his graduate degree from the University of Aberdeen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/03/2024 | 317 ( 0,01% ) | - $ | 30/06/2024 | |
| 27/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Anthony Culverwell
| Sociétés | Poste | Début |
|---|---|---|
| QUOIN PHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 28/10/2021 |
| TC BIOPHARM (HOLDINGS) PLC | Directeur/Membre du Conseil | 22/02/2022 |
Hox Therapeutics Ltd.
 Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Président | 13/11/2018 |
Safeguard Biosystems Holdings Ltd.
 Safeguard Biosystems Holdings Ltd. Medical SpecialtiesHealth Technology Safeguard Biosystems Holdings Ltd. engages in the development, manufacture, and sales of diagnostic tests for human and animal health; and food safety products. The company was founded on May 11, 2006 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 14/12/2006 |
| Sudbrook Associates LLP | Fondateur | 01/01/2005 |
Anciens postes connus de Anthony Culverwell
| Sociétés | Poste | Fin |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 25/09/2019 |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Directeur/Membre du Conseil | 01/07/2017 |
| INNOCOLL HOLDINGS PLC | Directeur/Membre du Conseil | 01/01/2017 |
Bioco Ltd.
 Bioco Ltd. BiotechnologyHealth Technology Bioco Ltd. operates as a British biotechnology company. The private company is based in Walsall, UK. | Directeur/Membre du Conseil | 01/10/2015 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Anthony Culverwell
| University of Aberdeen | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| QUOIN PHARMACEUTICALS, LTD. | Health Technology |
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Entreprise privées | 15 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
| Hoare Govett Ltd. | Finance |
| Merrill Lynch, Pierce, Fenner & Smith Ltd. | Finance |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Safeguard Biosystems Holdings Ltd.
Safeguard Biosystems Holdings Ltd. Medical SpecialtiesHealth Technology Safeguard Biosystems Holdings Ltd. engages in the development, manufacture, and sales of diagnostic tests for human and animal health; and food safety products. The company was founded on May 11, 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Jefferies International Ltd.
 Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Finance |
| Sudbrook Associates LLP | |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Innocoll Holdings Plc operates as a pharmaceutical company. It focuses on the development and commercialization of pharmaceutical technologies to meet healthcare challenges. The firm's late-stage product pipeline is focused on addressing patient needs for postsurgical pain management. The company was founded in 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
ToHealth Ltd.
 ToHealth Ltd. Medical/Nursing ServicesHealth Services ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner. | Health Services |
Hox Therapeutics Ltd.
Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Health Technology |
Bioco Ltd.
Bioco Ltd. BiotechnologyHealth Technology Bioco Ltd. operates as a British biotechnology company. The private company is based in Walsall, UK. | Health Technology |
